Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

United Therapeutics

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of United Therapeutics' 2013 cardiovasular sales performance.

Rare disease therapies head the ‘class of 2015’

Rare disease therapies head the ‘class of 2015’

have a treatment option in the form of Wellstat Therapeutics' Xuriden (uridine triacetate). ... USA. dinutuximab. Unituxin. neuroblastoma. anti-GD2 antibody. United Therapeutics. USA. elotuzumab. Empliciti.

FDA approvals hit 19-year high

FDA approvals hit 19-year high Orkambi (ivacaftor plus lumacaftor) and United Therapeutics' paediatric bran cancer therapy Unituxin (dinutuximab).

Actelion claims first approval for PAH therapy Uptravi

Actelion claims first approval for PAH therapy Uptravi Uptravi will compete in the US marketplace with another oral prostacyclin agonist - United Therapeutics' Orenitram (treprostinil) - and Actelion is banking that the data behind its new drug will allow it to

GSK earns expanded approval for Volibris in Europe

GSK earns expanded approval for Volibris in Europe s Adempas (riociguat) and United Therapeutics' Orenitram (trepostinil).

Gilead receives FDA approval for PAH combo

Gilead receives FDA approval for PAH combo Additionally there will be competition from Bayer's Adempas (riociguat), which was cleared by the FDA in 2013, and United Therapeutics' Remodulin (treprostinil).

1 2 3 4 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....